Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development
Open accessThe DOI matches its Crossref record; 240 of the 240 references it cites were found in a registry or an index.
Abstract
Highlights ► Virus-like particles (VLPs) are a class of recombinant subunit vaccines. ► VLPs resemble native viruses but lack infectious genetic material. ► VLPs are promising vaccines due to strong immunogenicity and safety. ► VLPs can be produced in prokaryotic or eukaryotic expression systems, or in vitro. ► VLP-based vaccine candidates targeting many diseases are in clinical development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
(2015) · Elsevier eBooks · doi:10.1016/c2012-1-00075-6 · Cited by 2,577
Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults
Falsey, A. R., Hennessey, P. A., Formica, M. A., Cox, C., & Walsh, E. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043951 · Cited by 2,226
Quadrivalent Vaccine against Human Papillomavirus to Prevent High-Grade Cervical Lesions
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa061741 · Cited by 2,055
Summary of product characteristics
(2013) · Pharmaceutical Medicine · doi:10.1093/med/9780199609147.003.0027 · Cited by 1,905
Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases
Garland, S. M., Hernandez-Avila, M., Wheeler, C. M., Perez, G., Harper, D. M., Leodolter, S., Tang, G. W. K., Ferris, D. G., Steben, M., Bryan, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061760 · Cited by 1,886
Harper, D. M., Franco, E. L., Wheeler, C., Ferris, D. G., Jenkins, D., Schuind, A., Zahaf, T., Innis, B., Naud, P., De Carvalho, N. S., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17398-4 · Cited by 1,643
Harper, D. M., Franco, E. L., Wheeler, C. M., Moscicki, A.-B., Romanowski, B., Roteli-Martins, C. M., Jenkins, D., Schuind, A., Costa Clemens, S. A., & Dubin, G. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68439-0 · Cited by 1,632
A Controlled Trial of a Human Papillomavirus Type 16 Vaccine
Koutsky, L. A., Ault, K. A., Wheeler, C. M., Brown, D. R., Barr, E., Alvarez, F. B., Chiacchierini, L. M., & Jansen, K. U. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020586 · Cited by 1,602
Villa, L. L., Costa, R. L., Petta, C. A., Andrade, R. P., Ault, K. A., Giuliano, A. R., Wheeler, C. M., Koutsky, L. A., Malm, C., Lehtinen, M., et al. (2005) · The Lancet Oncology · doi:10.1016/s1470-2045(05)70101-7 · Cited by 1,579
Nipah Virus: A Recently Emergent Deadly Paramyxovirus
Chua, K. B., Bellini, W. J., Rota, P. A., Harcourt, B. H., Tamin, A., Lam, S. K., Ksiazek, T. G., Rollin, P. E., Zaki, S. R., Shieh, W.-J., et al. (2000) · Science · doi:10.1126/science.288.5470.1432 · Cited by 1,395
Kirnbauer, R., Booy, F., Cheng, N., Lowy, D. R., & Schiller, J. T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12180 · Cited by 1,110
First Results of Phase 3 Trial of RTS,S/AS01 Malaria Vaccine in African Children
The RTS, S. C. T. P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102287 · Cited by 896
Synthesis and assembly of hepatitis B virus surface antigen particles in yeast
Valenzuela, P., Medina, A., Rutter, W. J., Ammerer, G., & Hall, B. D. (1982) · Nature · doi:10.1038/298347a0 · Cited by 877
Stoute, J. A., Slaoui, M., Heppner, D. G., Momin, P., Kester, K. E., Desmons, P., Wellde, B. T., Garçon, N., Krzych, U., Marchand, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701093360202 · Cited by 870
Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein
Jiang, X., Wang, M., Graham, D. Y., & Estes, M. K. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6527-6532.1992 · Cited by 860
Fatal encephalitis due to Nipah virus among pig-farmers in Malaysia
Chua, K. B., Goh, K. J., Wong, K. T., Kamarulzaman, A., Tan, P. S. K., Ksiazek, T. G., Zaki, S. R., Paul, G., Lam, S. K., & Tan, C. T. (1999) · The Lancet · doi:10.1016/s0140-6736(99)04299-3 · Cited by 853
Villa, L. L., Costa, R. L. R., Petta, C. A., Andrade, R. P., Paavonen, J., Iversen, O.-E., Olsson, S.-E., Høye, J., Steinwall, M., Riis-Johannessen, G., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603469 · Cited by 806
Gheysen, D., Jacobs, E., de Foresta, F., Thiriart, C., Francotte, M., Thines, D., & De Wilde, M. (1989) · Cell · doi:10.1016/0092-8674(89)90873-8 · Cited by 747
Human hepatitis B vaccine from recombinant yeast
McAleer, W. J., Buynak, E. B., Maigetter, R. Z., Wampler, D. E., Miller, W. J., & Hilleman, M. R. (1984) · Nature · doi:10.1038/307178a0 · Cited by 739
Mandell, Douglas, and Bennett's principles and practice of infectious diseases
Gillespie, S. H. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70159-6 · Cited by 705
An overview of the evolution of enterovirus 71 and its clinical and public health significance
McMinn, P. C. (2002) · FEMS Microbiology Reviews · doi:10.1016/s0168-6445(02)00070-0 · Cited by 699
Hildesheim, A., Herrero, R., Wacholder, S., Rodriguez, A. C., Solomon, D., Bratti, M. C., Schiller, J. T., Gonzalez, P., Dubin, G., Porras, C., et al. (2007) · JAMA · doi:10.1001/jama.298.7.743 · Cited by 666
Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles
Kirnbauer, R., Taub, J. W., Greenstone, H. L., Roden, R. B. S., Dürst, M., Gissmann, L., Lowy, D. R., & Schiller, J. T. (1993) · Journal of Virology · doi:10.1128/jvi.67.12.6929-6936.1993 · Cited by 608
Vaccines: past, present and future
Plotkin, S. A. (2005) · Nature Medicine · doi:10.1038/nm1209 · Cited by 592
Ault, K. A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60852-6 · Cited by 590
Virus-like particles: Passport to immune recognition
Grgacic, E. V. L., & Anderson, D. A. (2006) · Methods · doi:10.1016/j.ymeth.2006.07.018 · Cited by 582
Akahata, W., Yang, Z.-Y., Andersen, H., Sun, S., Holdaway, H. A., Kong, W.-P., Lewis, M. G., Higgs, S., Rossmann, M. G., Rao, S., et al. (2010) · Nature Medicine · doi:10.1038/nm.2105 · Cited by 515
Norovirus Vaccine against Experimental Human Norwalk Virus Illness
Atmar, R. L., Bernstein, D. I., Harro, C. D., Al-Ibrahim, M. S., Chen, W. H., Ferreira, J., Estes, M. K., Graham, D. Y., Opekun, A. R., Richardson, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1101245 · Cited by 490
Human Immune Responses to a Novel Norwalk Virus Vaccine Delivered in Transgenic Potatoes
Tacket, C. O., Mason, H. S., Losonsky, G., Estes, M. K., Levine, M. M., & Arntzen, C. J. (2000) · The Journal of Infectious Diseases · doi:10.1086/315653 · Cited by 481
Davis, B. S., Chang, G.-J. J., Cropp, B., Roehrig, J. T., Martin, D. A., Mitchell, C. J., Bowen, R., & Bunning, M. L. (2001) · Journal of Virology · doi:10.1128/jvi.75.9.4040-4047.2001 · Cited by 447
Hepatitis C Virus Structural Proteins Assemble into Viruslike Particles in Insect Cells
Baumert, T. F., Ito, S., Wong, D. T., & Liang, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.3827-3836.1998 · Cited by 397
A plant‐derived edible vaccine against hepatitis B virus
Kapusta, J., Modelska, A., Figlerowicz, M., Pniewski, T., Letellier, M., Lisowa, O., Yusibov, V., Koprowski, H., Plucienniczak, A., & Legocki, A. B. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.13.1796 · Cited by 386
Self-citationD’Aoust, M., Couture, M. M. ‐., Charland, N., Trépanier, S., Landry, N., Ors, F., & Vézina, L. (2010) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2009.00496.x · Cited by 371
Ebola Virus VP40 Drives the Formation of Virus-Like Filamentous Particles Along with GP
Noda, T., Sagara, H., Suzuki, E., Takada, A., Kida, H., & Kawaoka, Y. (2002) · Journal of Virology · doi:10.1128/jvi.76.10.4855-4865.2002 · Cited by 349
Cregg, J. M., Tschopp, J. F., Stillman, C., Siegel, R., Akong, M., Craig, W. S., Buckholz, R. G., Madden, K. R., Kellaris, P. A., Davis, G. R., et al. (1987) · Nature Biotechnology · doi:10.1038/nbt0587-479 · Cited by 334
M2e-based universal influenza A vaccine
Fiers, W., De Filette, M., Bakkouri, K. E., Schepens, B., Roose, K., Schotsaert, M., Birkett, A., & Saelens, X. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.07.007 · Cited by 334
Greenstone, H. L., Nieland, J. D., de Visser, K. E., Bruijn, M. L. H. D., Kirnbauer, R., Roden, R. B. S., Lowy, D. R., Kast, W. M., & Schiller, J. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1800 · Cited by 325
Virus-like particles: flexible platforms for vaccine development
Chackerian, B. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.3.381 · Cited by 321
Quan, F.-S., Huang, C., Compans, R. W., & Kang, S.-M. (2007) · Journal of Virology · doi:10.1128/jvi.02052-06 · Cited by 313
Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine
YUSIBOV, V (2002) · Vaccine · doi:10.1016/s0264-410x(02)00260-8 · Cited by 311
Self-citationChen, B. J., Leser, G. P., Morita, E., & Lamb, R. A. (2007) · Journal of Virology · doi:10.1128/jvi.00361-07 · Cited by 305
Bomsel, M., Tudor, D., Drillet, A.-S., Alfsen, A., Ganor, Y., Roger, M.-G., Mouz, N., Amacker, M., Chalifour, A., Diomede, L., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.01.015 · Cited by 293
Eleven years of Inflexal® V—a virosomal adjuvanted influenza vaccine
Herzog, C., Hartmann, K., Künzi, V., Kürsteiner, O., Mischler, R., Lazar, H., & Glück, R. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.05.029 · Cited by 292
Immunogenicity in humans of an edible vaccine for hepatitis B
Thanavala, Y., Mahoney, M., Pal, S., Scott, A., Richter, L., Natarajan, N., Goodwin, P., Arntzen, C. J., & Mason, H. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409899102 · Cited by 290
Bright, R. A., Carter, D. M., Daniluk, S., Toapanta, F. R., Ahmad, A., Gavrilov, V., Massare, M., Pushko, P., Mytle, N., Rowe, T., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.01.106 · Cited by 288
Influenza Virus Matrix Protein Is the Major Driving Force in Virus Budding
Gómez-Puertas, P., Albo, C., Pérez-Pastrana, E., Vivo, A., & Portela, A. (2000) · Journal of Virology · doi:10.1128/jvi.74.24.11538-11547.2000 · Cited by 287
Ebola Virus VP40-Induced Particle Formation and Association with the Lipid Bilayer
Jasenosky, L. D., Neumann, G., Lukashevich, I., & Kawaoka, Y. (2001) · Journal of Virology · doi:10.1128/jvi.75.11.5205-5214.2001 · Cited by 286 · cited 1×
“Also, VP40 matrix protein of Ebola virus has been shown to form VLPs when produced in mammalian cells [98] and could be a potential vaccine for preventing infections with Ebola virus.”
Tissot, A. C., Maurer, P., Nussberger, J., Sabat, R., Pfister, T., Ignatenko, S., Volk, H.-D., Stocker, H., Müller, P., Jennings, G. T., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60381-5 · Cited by 286
A vaccine against nicotine for smoking cessation: a randomized controlled trial
Cornuz, J., Zwahlen, S., Jungi, W. F., Osterwalder, J., Klingler, K., van Melle, G., Bangala, Y., Guessous, I., Müller, P., Willers, J., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002547 · Cited by 281
Landry, N., Ward, B. J., Trépanier, S., Montomoli, E., Dargis, M., Lapini, G., & Vézina, L.-P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015559 · Cited by 281
Maurer, P., Jennings, G. T., Willers, J., Rohner, F., Lindman, Y., Roubicek, K., Renner, W. A., Müller, P., & Bachmann, M. F. (2005) · European Journal of Immunology · doi:10.1002/eji.200526285 · Cited by 279
D’Aoust, M., Lavoie, P., Couture, M. M. ‐., Trépanier, S., Guay, J., Dargis, M., Mongrand, S., Landry, N., Ward, B. J., & Vézina, L. (2008) · Plant Biotechnology Journal · doi:10.1111/j.1467-7652.2008.00384.x · Cited by 279
Malaria Epitopes Expressed on the surface of Recombinant Tobacco Mosaic Virus
Turpen, T. H., Reinl, S. J., Charoenvit, Y., Hoffman, S. L., Fallarme, V., & Grill, L. K. (1995) · Nature Biotechnology · doi:10.1038/nbt0195-53 · Cited by 274
Hall, C. B. (2004) · Principles and Practice of Clinical Virology · doi:10.1002/0470020970.ch7 · Cited by 267
Warfield, K. L., Swenson, D. L., Olinger, G. G., Kalina, W. V., Aman, M. J., & Bavari, S. (2007) · The Journal of Infectious Diseases · doi:10.1086/520583 · Cited by 260
Mortola, E., & Roy, P. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.09.009 · Cited by 250
Kajigaya, S., Fujii, H., Field, A., Anderson, S., Rosenfeld, S., Anderson, L. J., Shimada, T., & Young, N. S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4646 · Cited by 249
PUSHKO, P., TUMPEY, T., BU, F., KNELL, J., ROBINSON, R., & SMITH, G. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.07.098 · Cited by 249
Ebola virus-like particles protect from lethal Ebola virus infection
Warfield, K. L., Bosio, C. M., Welcher, B. C., Deal, E. M., Mohamadzadeh, M., Schmaljohn, A., Aman, M. J., & Bavari, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2237038100 · Cited by 244
Bright, R. A., Carter, D. M., Crevar, C. J., Toapanta, F. R., Steckbeck, J. D., Cole, K. S., Kumar, N. M., Pushko, P., Smith, G., Tumpey, T. M., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001501 · Cited by 240
Licata, J. M., Johnson, R. F., Han, Z., & Harty, R. N. (2004) · Journal of Virology · doi:10.1128/jvi.78.14.7344-7351.2004 · Cited by 236
Recombinant Norwalk virus–like particles given orally to volunteers: Phase I study
Ball, J. M., Graham, D. Y., Opekun, A. R., Gilger, M. A., Guerrero, R. A., & Estes, M. K. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70548-2 · Cited by 227
El‐Kamary, S. S., Pasetti, M. F., Mendelman, P. M., Frey, S. E., Bernstein, D. I., Treanor, J. J., Ferreira, J., Chen, W. H., Sublett, R., Richardson, C., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/657087 · Cited by 226
Ambühl, P. M., Tissot, A. C., Fulurija, A., Maurer, P., Nussberger, J., Sabat, R., Nief, V., Schellekens, C., Sladko, K., Roubicek, K., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e32800ff5d6 · Cited by 219
Versatile Virus-Like Particle Carrier for Epitope Based Vaccines
Tissot, A. C., Renhofa, R., Schmitz, N., Cielens, I., Meijerink, E., Ose, V., Jennings, G. T., Saudan, P., Pumpens, P., & Bachmann, M. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009809 · Cited by 206
French, T. J., & Roy, P. (1990) · Journal of Virology · doi:10.1128/jvi.64.4.1530-1536.1990 · Cited by 191
Wiessner, C., Wiederhold, K.-H., Tissot, A. C., Frey, P., Danner, S., Jacobson, L. H., Jennings, G. T., Luond, R., Ortmann, R., Reichwald, J., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0293-11.2011 · Cited by 190
Production of Human Papillomavirus Type 16 Virus-Like Particles in Transgenic Plants
Biemelt, S., Sonnewald, U., Galmbacher, P., Willmitzer, L., & Müller, M. (2003) · Journal of Virology · doi:10.1128/jvi.77.17.9211-9220.2003 · Cited by 190
Gavilanes, F., González-Ros, J. M., & Peterson, D. L. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)34448-x · Cited by 185
Martin, J. E., Pierson, T. C., Hubka, S., Rucker, S., Gordon, I. J., Enama, M. E., Andrews, C. A., Xu, Q., Davis, B. S., Nason, M., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/523650 · Cited by 185
Pimentel, T. A. P. F., Yan, Z., Jeffers, S. A., Holmes, K. V., Hodges, R. S., & Burkhard, P. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00746.x · Cited by 182
The FUTURE II Study Group (2007) · The Journal of Infectious Diseases · doi:10.1086/522864 · Cited by 182
Bitter, G. A., & Egan, K. M. (1984) · Gene · doi:10.1016/0378-1119(84)90002-7 · Cited by 177
Virus-Like Particle Vaccine Conferred Complete Protection Against a Lethal Influenza Virus Challenge
Galarza, J. M., Latham, T., & Cupo, A. (2005) · Viral Immunology · doi:10.1089/vim.2005.18.365 · Cited by 176
French, T. J., Marshall, J. J., & Roy, P. (1990) · Journal of Virology · doi:10.1128/jvi.64.12.5695-5700.1990 · Cited by 175
Kaba, S. A., Brando, C., Guo, Q., Mittelholzer, C., Raman, S., Tropel, D., Aebi, U., Burkhard, P., & Lanar, D. E. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901957 · Cited by 175
Requirements for the Assembly and Release of Newcastle Disease Virus-Like Particles
Pantua, H. D., McGinnes, L. W., Peeples, M. E., & Morrison, T. G. (2006) · Journal of Virology · doi:10.1128/jvi.00726-06 · Cited by 175
Insect Baculoviruses Strongly Potentiate Adaptive Immune Responses by Inducing Type I IFN
Hervas-Stubbs, S., Rueda, P., Lopez, L., & Leclerc, C. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.4.2361 · Cited by 175
Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity
Song, J.-M., Wang, B.-Z., Park, K.-M., Van Rooijen, N., Quan, F.-S., Kim, M.-C., Jin, H.-T., Pekosz, A., Compans, R. W., & Kang, S.-M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014538 · Cited by 175
FluBlok, a recombinant hemagglutinin influenza vaccine
Cox, M. M. J., PATRIARCA, P. A., & Treanor, J. J. (2008) · Influenza and Other Respiratory Viruses · doi:10.1111/j.1750-2659.2008.00053.x · Cited by 173
Sasagawa, T., Pushko, P., Steers, G., Gschmeissner, S. E., Hajibagheri, M. A. N., Finch, J. T., Crawford, L. V., & Tommasino, M. (1995) · Virology · doi:10.1016/s0042-6822(95)80027-1 · Cited by 171
Murata, K., Lechmann, M., Qiao, M., Gunji, T., Alter, H. J., & Liang, T. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1131929100 · Cited by 170
Influenza virosomes as a vaccine adjuvant and carrier system
Moser, C., Amacker, M., & Zurbriggen, R. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.15 · Cited by 169
Deml, L., Speth, C., Dierich, M. P., Wolf, H. J., & Wagner, R. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2004.06.028 · Cited by 168
Laurent, S., Vautherot, J. F., Madelaine, M. F., Le Gall, G., & Rasschaert, D. (1994) · Journal of Virology · doi:10.1128/jvi.68.10.6794-6798.1994 · Cited by 164
The expression of hybrid HIV:Ty virus-like particles in yeast
Adams, S. E., Dawson, K. M., Gull, K., Kingsman, S. M., & Kingsman, A. J. (1987) · Nature · doi:10.1038/329068a0 · Cited by 164
Jansen, K. U., Rosolowsky, M., Schultz, L. D., Markus, H. Z., Cook, J. C., Donnelly, J. J., Martinez, D., Ellis, R. W., & Shaw, A. R. (1995) · Vaccine · doi:10.1016/0264-410x(95)00103-8 · Cited by 164
Ball, J. M., Hardy, M. E., Atmar, R. L., Conner, M. E., & Estes, M. K. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.1345-1353.1998 · Cited by 160
Large-scale production of recombinant hepatitis B surface antigen from Pichia pastoris
Hardy, E., Martı́nez, E., Diago, D., Díaz, R., González, D., & Herrera, L. (2000) · Journal of Biotechnology · doi:10.1016/s0168-1656(99)00201-1 · Cited by 156
Christensen, N. D., Höpfl, R. M., DiAngelo, S. L., Cladel, N. M., Patrick, S. D., Welsh, P. A., Budgeon, L. R., Reed, C. A., & Kreider, J. W. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-9-2271 · Cited by 152
Influenza virosomes as vaccine adjuvant and carrier system
Moser, C., Müller, M., Kaeser, M. D., Weydemann, U., & Amacker, M. (2013) · Expert Review of Vaccines · doi:10.1586/14760584.2013.811195 · Cited by 150
Vassileva, A., Chugh, D. A., Swaminathan, S., & Khanna, N. (2001) · Journal of Biotechnology · doi:10.1016/s0168-1656(01)00254-1 · Cited by 149
Role of Natural Killer Cells in Innate Protection against Lethal Ebola Virus Infection
Warfield, K. L., Perkins, J. G., Swenson, D. L., Deal, E. M., Bosio, C. M., Aman, M. J., Yokoyama, W. M., Young, H. A., & Bavari, S. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032141 · Cited by 148
Martelli, P. R., Ferrari, L., Morganti, M. M., Angelis, E. D., Bonilauri, P., Guazzetti, S., Caleffi, A., & Borghetti, P. (2010) · Veterinary Microbiology · doi:10.1016/j.vetmic.2010.12.008 · Cited by 147
Wang, B., Quan, F., Kang, S., Bozja, J., Skountzou, I., & Compans, R. W. (2008) · Journal of Virology · doi:10.1128/jvi.01076-08 · Cited by 147
Grillberger, L., Kreil, T. R., Nasr, S., & Reiter, M. (2009) · Biotechnology Journal · doi:10.1002/biot.200800241 · Cited by 144
Brown, C. S., van Lent, J. W. M., Vlak, J. M., & Spaan, W. J. M. (1991) · Journal of Virology · doi:10.1128/jvi.65.5.2702-2706.1991 · Cited by 142
Virus assembly, allostery and antivirals
Zlotnick, A., & Mukhopadhyay, S. (2010) · Trends in Microbiology · doi:10.1016/j.tim.2010.11.003 · Cited by 142
Murawski, M. R., McGinnes, L. W., Finberg, R. W., Kurt‐Jones, E. A., Massare, M. J., Smith, G., Heaton, P. M., Fraire, A. E., & Morrison, T. G. (2009) · Journal of Virology · doi:10.1128/jvi.01709-09 · Cited by 140
Denis, J., Majeau, N., Acosta‐Ramírez, E., Savard, C., Bédard, M.-C., Simard, S., Lecours, K., Bolduc, M., Paré, C., Willems, B. E., et al. (2007) · Virology · doi:10.1016/j.virol.2007.01.011 · Cited by 138
Buonaguro, L., Tornesello, M. L., Tagliamonte, M., Gallo, R. C., Wang, L., Kamin‐Lewis, R., Abdelwahab, S. F., Lewis, G. K., & Buonaguro, F. M. (2006) · Journal of Virology · doi:10.1128/jvi.00050-06 · Cited by 137
Hepatitis B vaccines: Protective efficacy and therapeutic potential
Michel, M.-L., & Tiollais, P. (2010) · Pathologie Biologie · doi:10.1016/j.patbio.2010.01.006 · Cited by 136
Human papillomavirus infection and the development of cervical cancer and related genital neoplasias
Paavonen, J. A. (2007) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(07)60015-0 · Cited by 135
López-Macías, C. I. R., Ferat-Osorio, E. A., Tenorio-Calvo, A. V., Isibasi, A., Talavera, J. O., Arteaga-Ruiz, O., Arriaga‐Pizano, L., Hickman, S. P., Allende, M. C., Lenhard, K., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.07.099 · Cited by 135
Swenson, D. L., Warfield, K. L., Negley, D. L., Schmaljohn, A. L., Aman, M. J., & Bavari, S. (2005) · Vaccine · doi:10.1016/j.vaccine.2004.11.070 · Cited by 133
Mahmood, K., Bright, R. A., Mytle, N., Carter, D. M., Crevar, C. J., Achenbach, J. E., Heaton, P. M., Tumpey, T. M., & Ross, T. M. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.084 · Cited by 133
Diminsky, D., Schirmbeck, R., Reimann, J., et al. (1997) · Vaccine · doi:10.1016/s0264-410x(96)00239-3 · Cited by 131
Recent progress in the development of plant derived vaccines
Yusibov, V. M., & Rabindran, S. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.8.1173 · Cited by 130
Self-citationGalarza, J. M., Latham, T. E., & Cupo, A. (2005) · Viral Immunology · doi:10.1089/vim.2005.18.244 · Cited by 129
Dalgleish, A. G., Chanh, T. C., Kennedy, R. C., Kanda, P., Clapham, P. R., & Weiss, R. A. (1988) · Virology · doi:10.1016/0042-6822(88)90674-5 · Cited by 127
Nuclear assembly of polyomavirus capsids in insect cells expressing the major capsid protein VP1
Montross, L. K., Watkins, S. C., Moreland, R. B., Mamon, H. J., Caspar, D. L. D., & Garcea, R. L. (1991) · Journal of Virology · doi:10.1128/jvi.65.9.4991-4998.1991 · Cited by 126
Viruslike Particle Vaccine Induces Protection Against Respiratory Syncytial Virus Infection in Mice
Quan, F.-S., Kim, Y., Lee, S., Yi, H., Kang, S.-M., Bozja, J., Moore, M. L., & Compans, R. W. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir474 · Cited by 125
Jeong, S., Qiao, M., Nascimbeni, M., Hu, Z., Rehermann, B., Murthy, K. K., & Liang, T. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.13.6995-7003.2004 · Cited by 124
Paliard, X., Liu, Y., Wagner, R., Wolf, H. J., Baenziger, J., & Walker, C. M. (2000) · AIDS Research and Human Retroviruses · doi:10.1089/088922200309368 · Cited by 121
Belyaev, A. S., & Roy, P. (1993) · Nucleic Acids Research · doi:10.1093/nar/21.5.1219 · Cited by 121
Bertolotti‐Ciarlet, A., Ciarlet, M., Crawford, S. E., Conner, M. E., & Estes, M. K. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00308-6 · Cited by 120
Wiedermann, U., Wiltschke, C., Jasińska, J., Kundi, M., Zurbriggen, R., Garner‐Spitzer, E., Bartsch, R., Steger, G. G., Pehamberger, H., Scheiner, O., et al. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0666-9 · Cited by 116
Li, M., Schmitt, P. T., Li, Z., McCrory, T. S., He, B., & Schmitt, A. P. (2009) · Journal of Virology · doi:10.1128/jvi.00421-09 · Cited by 114
Assembly of human severe acute respiratory syndrome coronavirus-like particles
Ho, Y., Lin, P.-H., Liu, C. Y. Y., Lee, S.-P., & Chao, Y.-C. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.04.111 · Cited by 114
De Bernardis, F., Liu, H., O’Mahony, R., La Valle, R., Bartollino, S., Sandini, S., Grant, S., Brewis, N., Tomlinson, I., Basset, R. C., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/509891 · Cited by 114
Protective efficacy of virus-like particles for bluetongue disease
Roy, P., French, T., & Erasmus, B. J. (1992) · Vaccine · doi:10.1016/0264-410x(92)90415-g · Cited by 113
Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial
Thompson, F. M., Porter, D. W., Okitsu, S. L., Westerfeld, N., Vogel, D., Todryk, S. M., Poulton, I. D., Correa, S., Hutchings, C. L., Berthoud, T. K., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001493 · Cited by 112
Mammalian Expression of Virus-Like Particles for Advanced Mimicry of Authentic Influenza Virus
Wu, C.-Y., Yeh, Y.-C., Yang, Y., Chou, C., Liu, M., Wu, H.-S., Chan, J.-T., & Hsiao, P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009784 · Cited by 112
Ebola and Marburg virus-like particles activate human myeloid dendritic cells
Bosio, C. M., Moore, B. D., Warfield, K. L., Ruthel, G. T., Mohamadzadeh, M., Aman, M. J., & Bavari, S. (2004) · Virology · doi:10.1016/j.virol.2004.05.025 · Cited by 111
Multivesicular Bodies as a Platform for Formation of the Marburg Virus Envelope
Kolesnikova, L., Berghöfer, B., Bamberg, S., & Becker, S. (2004) · Journal of Virology · doi:10.1128/jvi.78.22.12277-12287.2004 · Cited by 111
Ye, L., Lin, J., Sun, Y., Bennouna, S., Lo, M. K., Wu, Q., Bu, Z., Pulendran, B., Compans, R. W., & Yang, C. (2006) · Virology · doi:10.1016/j.virol.2006.03.021 · Cited by 110
Chang, G. J., Hunt, A. R., Holmes, D. A., Springfield, T., Chiueh, T., Roehrig, J. T., & Gubler, D. J. (2003) · Virology · doi:10.1016/s0042-6822(02)00028-4 · Cited by 108
High-level expression of the HIV-1 Pr55gag polyprotein in transgenic tobacco chloroplasts
Scotti, N., Alagna, F., Ferraiolo, E., Formisano, G., Sannino, L., Buonaguro, L., Stradis, A. D., Vitale, A., Monti, L. M., Grillo, S., et al. (2009) · Planta · doi:10.1007/s00425-009-0898-2 · Cited by 106
Oliveira, G. A., Wetzel, K., Calvo‐Calle, J. M., Nussenzweig, R. S., Schmidt, A., Birkett, A. J., Dubovsky, F., Tierney, E. L., Gleiter, C. H., Boehmer, G., et al. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3587-3597.2005 · Cited by 106
Dupuy, C., Buzoni–Gatel, D., Touzé, A., Bout, D. T., & Coursaget, P. (1999) · Journal of Virology · doi:10.1128/jvi.73.11.9063-9071.1999 · Cited by 104
Haynes, J. R., Dokken, L., Wiley, J. A., Cawthon, A. G., Bigger, J. E., Harmsen, A. G., & Richardson, C. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.11.011 · Cited by 103
McGinnes, L. W., Gravel, K. A., Finberg, R. W., Kurt‐Jones, E. A., Massare, M. J., Smith, G., Schmidt, M. R., & Morrison, T. G. (2010) · Journal of Virology · doi:10.1128/jvi.01861-10 · Cited by 103
Virus-Like Particle Vaccine Protects against 2009 H1N1 Pandemic Influenza Virus in Mice
Quan, F., Vunnava, A., Compans, R. W., & Kang, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009161 · Cited by 101
Rennermalm, A., Li, Y., Bohaufs, L., Jarstrand, C., Brauner, A., Brennan, F. R., & Flock, J. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00080-9 · Cited by 101
Marburg virus-like particles protect guinea pigs from lethal Marburg virus infection
Warfield, K. L., Swenson, D. L., Negley, D. L., Schmaljohn, A. L., Aman, M. J., & Bavari, S. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.01.063 · Cited by 99
Nardin, E. H., Oliveira, G. A., Calvo‐Calle, J. M., Wetzel, K., Maier, C., Birkett, A. J., Sarpotdar, P. P., Corado, M. L., Thornton, G. B., & Schmidt, A. (2004) · Infection and Immunity · doi:10.1128/iai.72.11.6519-6527.2004 · Cited by 99
Pushko, P., Tumpey, T. M., Hoeven, N. V., Belser, J. A., Robinson, R., Nathan, M., Smith, G., Wright, D. C., & Bright, R. A. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.02.059 · Cited by 99
Nipah virus—a potential agent of bioterrorism?
Lam, S.-K. (2003) · Antiviral Research · doi:10.1016/s0166-3542(02)00204-8 · Cited by 98
Recombinant vaccine for canine parvovirus in dogs
de Turiso, J. A. L., Cortés, E., Martínez, C., de Ybáñez, R. R., Simarro, I., Vela, C., & Casal, J. I. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.2748-2753.1992 · Cited by 97
Song, J.-M., Hossain, J., Yoo, D., Lipatov, A. S., Davis, C. T., Quan, F., Chen, L., Hogan, R. J., Donis, R. O., Compans, R. W., et al. (2010) · Virology · doi:10.1016/j.virol.2010.05.034 · Cited by 97
HIV type 1 Gag virus-like particle budding from spheroplasts of Saccharomyces cerevisiae
Sakuragi, S., Goto, T., Sano, K., & Morikawa, Y. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082281199 · Cited by 97
Zeng, C., Wentz, M. J., Cohen, J., Estes, M. K., & Ramig, R. F. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.2736-2742.1996 · Cited by 95
Production of porcine parvovirus empty capsids with high immunogenic activity
Martínez, C., Dalsgaard, K., de Turiso, J. A. L., Cortés, E., Vela, C., & Casal, J. I. (1992) · Vaccine · doi:10.1016/0264-410x(92)90090-7 · Cited by 94
A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs
Quan, F., Steinhauer, D. A., Huang, C., Ross, T. M., Compans, R. W., & Kang, S. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.03.055 · Cited by 94
Expression, purification and characterization of enterovirus-71 virus-like particles
Chung, Y.-C., Huang, J., Lai, C., Sheng, H.-C., Shih, S.-R., Ho, M.-S., & Hu, Y.-C. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i6.921 · Cited by 93
Lünsdorf, H., Gurramkonda, C., Adnan, A., Khanna, N., & Rinas, U. (2011) · Microbial Cell Factories · doi:10.1186/1475-2859-10-48 · Cited by 92
Protection against lethal challenge by Ebola virus-like particles produced in insect cells
Sun, Y., Carrion, R., Ye, L., Wen, Z., Ro, Y., Brasky, K. M., Ticer, A. E., Schwegler, E. E., Patterson, J. L., Compans, R. W., et al. (2008) · Virology · doi:10.1016/j.virol.2008.09.020 · Cited by 92
Lacasse, P., Denis, J., Lapointe, R., Leclerc, D., & Lamarre, A. (2007) · Journal of Virology · doi:10.1128/jvi.01811-07 · Cited by 92
Pushko, P., Pearce, M. B., Ahmad, A., Tretyakova, I., Smith, G., Belser, J. A., & Tumpey, T. M. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.06.068 · Cited by 91
Yamshchikov, G. V., Ritter, G., Vey, M., & Compans, R. W. (1995) · Virology · doi:10.1006/viro.1995.9955 · Cited by 91
Overton, H. A., Fujii, Y. R., Price, I. R., & Jones, I. M. (1989) · Virology · doi:10.1016/0042-6822(89)90357-7 · Cited by 90
Wang, B., Xu, R., Quan, F., Kang, S., Wang, L., & Compans, R. W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013972 · Cited by 89
Durrani, Z., McInerney, T. L., McLain, L., Jones, T. D., Bellaby, T., Brennan, F. R., & Dimmock, N. J. (1998) · Journal of Immunological Methods · doi:10.1016/s0022-1759(98)00145-8 · Cited by 88
Xia, M., Farkas, T., & Jiang, X. (2006) · Journal of Medical Virology · doi:10.1002/jmv.20762 · Cited by 88
Yuan, L., Geyer, A., Hodgins, D. C., Fan, Z., Qian, Y., Chang, K., Crawford, S. E., Parreño, V. G., Ward, L., Estes, M. K., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.8843-8853.2000 · Cited by 88
Lico, C., Mancini, C., Italiani, P., Betti, C., Boraschi, D., Benvenuto, E., & Baschieri, S. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.06.045 · Cited by 87
Wu, L. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00428-6 · Cited by 86
Filovirus‐Like Particles Produced in Insect Cells: Immunogenicity and Protection in Rodents
Warfield, K. L., Posten, N. A., Swenson, D. L., Olinger, G. G., Esposito, D., Gillette, W., Hopkins, R. F., Costantino, J. A., Panchal, R. G., Hartley, J. L., et al. (2007) · The Journal of Infectious Diseases · doi:10.1086/520612 · Cited by 85
Shchelkunov, S. N., Salyaev, R. K., Pozdnyakov, S. G., Rekoslavskaya, N. I., Ae, N., Ryzhova, T. S., Sumtsova, V. M., Pakova, N. V., Mishutina, U. O., Копытина, Т. В., et al. (2006) · Biotechnology Letters · doi:10.1007/s10529-006-9028-4 · Cited by 83
Influenza virus-like particle vaccines
Haynes, J. R. (2009) · Expert Review of Vaccines · doi:10.1586/erv.09.8 · Cited by 83
Skountzou, I., Quan, F., Gangadhara, S., Ye, L., Vzorov, A. N., Selvaraj, P., Jacob, J., Compans, R. W., & Kang, S. (2006) · Journal of Virology · doi:10.1128/jvi.01692-06 · Cited by 83
Self-assembly of Severe Acute Respiratory Syndrome Coronavirus Membrane Protein
Tseng, Y.-T., Wang, S.-M., Huang, K.-J., Lee, A. I.-R., Chiang, C.-C., & Wang, C.-T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.030270 · Cited by 82
Tsunetsugu‐Yokota, Y., Morikawa, Y., Isogai, M., Kawana‐Tachikawa, A., Odawara, T., Nakamura, T., Grassi, M. F. R., Autran, B., & Iwamoto, A. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10250-10259.2003 · Cited by 82
Kamphuis, T., Meijerhof, T., Stegmann, T., Lederhofer, J., Wilschut, J., & de Haan, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036812 · Cited by 81
Matić, S., Rinaldi, R., Masenga, V., & Noris, E. (2011) · BMC Biotechnology · doi:10.1186/1472-6750-11-106 · Cited by 81
Effect of Ebola virus proteins GP, NP and VP35 on VP40 VLP morphology
Johnson, R. F., Bell, P. L., & Harty, R. N. (2006) · Virology Journal · doi:10.1186/1743-422x-3-31 · Cited by 80
Virus-Like Particles Induce MHC Class I-Restricted T-Cell Responses
Schirmbeck, R., Böhm, W., & Reimann, J. (1996) · Intervirology · doi:10.1159/000150482 · Cited by 79
Vaccine Potential of Nipah Virus-Like Particles
Walpita, P., Barr, J. A., Sherman, M. B., Basler, C. F., & Wang, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018437 · Cited by 78
Birkett, A. J., Lyons, K., Schmidt, A., Boyd, D., Oliveira, G. A., Siddique, A., Nussenzweig, R. S., Calvo‐Calle, J. M., & Nardin, E. H. (2002) · Infection and Immunity · doi:10.1128/iai.70.12.6860-6870.2002 · Cited by 78
Flavivirus DNA Vaccines: Current Status and Potential
Chang, G. J., Davis, B. S., Hunt, A. R., HOLMES, D. A., & Kuno, G. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb02703.x · Cited by 76
Mok, H., Lee, S., Utley, T. J., Shepherd, B. E., Polosukhin, V. V., Collier, M. L., Davis, N. L., Johnston, R. E., & Crowe, J. E. (2007) · Journal of Virology · doi:10.1128/jvi.01351-07 · Cited by 75
Kosukegawa, A., Arisaka, F., Takayama, M., Yajima, H., Kaidow, A., & Handa, H. (1996) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(95)00184-0 · Cited by 75
Bräutigam, S., Snezhkov, E., & Bishop, D. H. L. (1993) · Virology · doi:10.1006/viro.1993.1067 · Cited by 72
Pushko, P., Kort, T., Nathan, M., Pearce, M. B., Smith, G., & Tumpey, T. M. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.04.093 · Cited by 72
Szécsi, J., Boson, B., Johnsson, P., Dupeyrot-Lacas, P., Matrosovich, M. N., Klenk, H. D., Klatzmann, D., Volchkov, V. E., & Cosset, F. (2006) · Virology Journal · doi:10.1186/1743-422x-3-70 · Cited by 72
Takimoto, T., Hurwitz, J. L., Coleclough, C., Prouser, C., Krishnamurthy, S., Zhan, X., Boyd, K. L., Scroggs, R. A., Brown, B., Nagai, Y., et al. (2004) · Journal of Virology · doi:10.1128/jvi.78.11.6043-6047.2004 · Cited by 71
Human respiratory syncytial virus vaccine antigen produced in plants
Belanger, H., Fleysh, N., Cox, S., Hartman, G., Deka, D., Trudel, M., Koprowski, H., & Yusibov, V. M. (2000) · The FASEB Journal · doi:10.1096/fj.00-0144com · Cited by 69
Self-citationYu, J., Kim, S., Lee, J.-B., & Chang, J. (2007) · Journal of Virology · doi:10.1128/jvi.02372-07 · Cited by 68
Cech, P. G., Aebi, T., Shomari, M., Mpina, M., Machunda, E. B., Westerfeld, N., Stoffel, S. A., Zurbriggen, R., Pluschke, G., Tanner, M., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022273 · Cited by 68
Zhan, X., Hurwitz, J. L., Krishnamurthy, S., Takimoto, T., Boyd, K. L., Scroggs, R. A., Surman, S. L., Portner, A., & Slobod, K. S. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.10.038 · Cited by 67
Kammer, A. R., Amacker, M., Rasi, S., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.07.052 · Cited by 66
Virus-Like Particles as a Vaccine Delivery System: Myths and Facts
Roy, P., & Noad, R. J. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1132-2_11 · Cited by 64
Lu, X., Chen, Y., Bai, B., Hu, H., Tao, L., Yang, J., Chen, J., Chen, Z., Hú, Z., & Wang, H. (2007) · Immunology · doi:10.1111/j.1365-2567.2007.02676.x · Cited by 63
Matassov, D., Cupo, A., & Galarza, J. M. (2007) · Viral Immunology · doi:10.1089/vim.2007.0027 · Cited by 62
Takehara, K., Ireland, D. C., & Bishop, D. H. L. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-11-2763 · Cited by 62
Betenbaugh, M. J., Yu, M., Kuehl, K. A., White, J., Pennock, D. G., Spik, K. W., & Schmaljohn, C. S. (1995) · Virus Research · doi:10.1016/0168-1702(95)00053-s · Cited by 61
Microbial production of virus-like particle vaccine protein at gram-per-litre levels
Liew, M. W. O., Rajendran, A., & Middelberg, A. P. J. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.08.010 · Cited by 60
Bai, B., Hu, Q., Hu, H., Zhou, P., Shi, Z., Meng, J., Lu, B., Huang, Y., Mao, P., & Wang, H. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002685 · Cited by 59
Genton, B., Pluschke, G., Degen, L., Kammer, A. R., Westerfeld, N., Okitsu, S. L., Schroller, S., Vounatsou, P., Mueller, M. M., Tanner, M., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001018 · Cited by 59
Flavivirus DNA vaccines: current status and potential.
Chang, G. J., Davis, B. S., Hunt, A. R., Holmes, D. A., & Kuno, G. (2001) · PubMed · Cited by 58
Okitsu, S. L., Silvie, O., Westerfeld, N., Curcic, M., Kammer, A. R., Mueller, M. S., Sauerwein, R. W., Robinson, J. A., Genton, B., Mazier, D., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001278 · Cited by 58
Palker, T. J., Monteiro, J. M., Martin, M. M., Kakareka, C., Smith, J. F., Cook, J. C., Joyce, J. G., & Jansen, K. U. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00093-7 · Cited by 58
Jones, B. G., Zhan, X., Mishin, V. P., Slobod, K. S., Surman, S. L., Russell, C. J., Portner, A., & Hurwitz, J. L. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.041 · Cited by 58
Liu, Y., Cocka, L. J., Okumura, A., Zhang, Y., Sunyer, J. O., & Harty, R. N. (2009) · Journal of Virology · doi:10.1128/jvi.02034-09 · Cited by 58
Stegmann, T., Kamphuis, T., Meijerhof, T., Goud, E., de Haan, A., & Wilschut, J. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.06.041 · Cited by 56
Engineered Synthetic Virus‐Like Particles and Their Use in Vaccine Delivery
Ghasparian, A., Riedel, T., Koomullil, J. M., Moehle, K., Gorba, C., Svergun, D. I., Perriman, A. W., Mann, S., Tamborrini, M., Pluschke, G., et al. (2010) · ChemBioChem · doi:10.1002/cbic.201000536 · Cited by 56
Nasal Immunization of Mice with Virus-Like Particles Protects Offspring against Rotavirus Diarrhea
Coste, A. T., Sirard, J., Johansen, K., Cohen, J., & Kraehenbühl, J.-P. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.8966-8971.2000 · Cited by 56
Steven, A. C., Trus, B. L., Booy, F. P., Cheng, N., Zlotnick, A., Castón, J. R., & Conway, J. F. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.10.9271358 · Cited by 55
González, A., NGUYEN, T. V., Azevedo, M. S. P., JEONG, K., AGARIB, F., Iosef, C., CHANG, K., Lövgren-Bengtsson, K., Morein, B., & Saif, L. J. (2004) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2004.02395.x · Cited by 55
Cited by
Zhao, L., Seth, A., Wibowo, N., Zhao, C.-X., Mitter, N., Yu, C., & Middelberg, A. P. J. (2014) · Vaccine · doi:10.1016/j.vaccine.2013.11.069 · Cited by 919
Major findings and recent advances in virus–like particle (VLP)-based vaccines
Mohsen, M. O., Zha, L., Cabral-Miranda, G., & Bachmann, M. F. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.08.014 · Cited by 555
Modern Subunit Vaccines: Development, Components, and Research Opportunities
Moyle, P. M., & Toth, I. (2013) · ChemMedChem · doi:10.1002/cmdc.201200487 · Cited by 464
Ma, J., Bruce, T. J., Jones, E. M., & Cain, K. D. (2019) · Microorganisms · doi:10.3390/microorganisms7110569 · Cited by 424
Bioengineering virus‐like particles as vaccines
Lua, L. H. L., Connors, N. K., Sainsbury, F., Chuan, Y. P., Wibowo, N., & Middelberg, A. P. J. (2014) · Biotechnology and Bioengineering · doi:10.1002/bit.25159 · Cited by 355
Metadata
- Authors
- Kushnir, N., Streatfield, S. J., & Yusibov, V.
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2012-12
- Volume
- 31
- Issue
- 1
- Pages
- 58-83
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W2120321866
- Cited by
- 587
- References
- 240
- FWCI
- 12.78
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.